Abstract

Rotavirus gastroenteritis is an important cause of childhood morbidity and mortality in Kenya. In July 2014, Kenya introduced the rotavirus vaccine into her national immunization program. Although immunization coverage is crucial in assessing the real-world impact of this vaccine, variability in the vaccine coverage across the country is likely to occur. In view of this, we estimated the extent of coverage for the rotavirus vaccine at two socio-economically different sub-counties using the administrative data. The findings indicate disparities in vaccine coverage and access between the sub-counties and, thus, underscore the need to strengthen immunization systems to facilitate timely, accessible, and equitable vaccine delivery across the country. Both sub-counties recorded high vaccine dropout, suggestive of poor utilization of the vaccine. In this regard, increased social mobilization is needed to encourage vaccine compliance and to enhance tracking of vaccine defaulters. While efforts to improve the accuracy of the administrative coverage estimates are crucial, vaccination coverage surveys will be needed to verify the administrative coverage data and help identify specific factors relating to rotavirus vaccine coverage in the country.

Highlights

  • Kiambu sub-county is located in Kiambu County, Central Kenya, on the outskirts of Nairobi, the capital of Kenya

  • There was a distinct variation in the extent of rotavirus vaccine coverage between Kiambu and Mbita subcounties

  • ANumber of children aged

Read more

Summary

Introduction

Methods Kiambu sub-county is located in Kiambu County, Central Kenya, on the outskirts of Nairobi, the capital of Kenya. According to the 2014 Kenya Demographic and Health Survey (KDHS) [14], 82.8% of children aged 12–23 months in this area were fully vaccinated. Mbita sub-county is located on the shores of Lake Victoria in Homa Bay County, Western Kenya, and about 400 km west of Nairobi. Homa Bay County is among the poorest in Kenya with its GDP of 0.3 billion USD accounting for only 1.2% of the national GDP [13]. According to the 2014 KDHS, only 53.7% of children aged 12–23 months in this area were fully immunized [14]. Over the first 20 years of its introduction in Kenya, the rotavirus vaccine is predicted to avert 60,935 undiscounted deaths and 216,454 hospital admissions among children aged

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call